
浏览全部资源
扫码关注微信
海南省中医院, 海口 570000
许日明,主治医师,从事中西医结合骨科的临床工作,E-mail:948276313@qq.com
周理,硕士,副主任医师,从事中西医结合骨科的临床工作,E-mail:17982100@qq.com
网络出版日期:2019-12-13,
纸质出版日期:2020-07-05
移动端阅览
许日明,陈美雄,林业武等.从肾论治绝经后膝骨关节炎肝肾亏虚证的临床观察[J].中国实验方剂学杂志,2020,26(13):150-155.
XU Ri-ming,CHEN Mei-xiong,LIN Ye-wu,et al.Clinical Efficacy of Postmenopausal Knee Osteoarthritis with Liver and Kidney Deficiencies Based on Theory of Syndrome Differentiation and Treatment of Kidney[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(13):150-155.
许日明,陈美雄,林业武等.从肾论治绝经后膝骨关节炎肝肾亏虚证的临床观察[J].中国实验方剂学杂志,2020,26(13):150-155. DOI: 10.13422/j.cnki.syfjx.20200334.
XU Ri-ming,CHEN Mei-xiong,LIN Ye-wu,et al.Clinical Efficacy of Postmenopausal Knee Osteoarthritis with Liver and Kidney Deficiencies Based on Theory of Syndrome Differentiation and Treatment of Kidney[J].Chinese Journal of Experimental Traditional Medical Formulae,2020,26(13):150-155. DOI: 10.13422/j.cnki.syfjx.20200334.
目的
2
评价从肾论治的左归丸加减治疗绝经后膝骨关节炎(KOA)肝肾亏虚证的临床疗效及对内分泌激素和软骨代谢的影响。
方法
2
将140例KOA患者根据随机按数字表法分为对照组和观察组各70例。两组患者均口服予盐酸氨基葡萄糖胶囊,1粒/次,2次/d,疗程共12周,疼痛明显加用塞来昔布胶囊,0.2 g/次,1次/d,共4周。对照组口服抗骨增生丸,3 g/次,3次/d。观察组加服左归丸加减,1剂/d,两组疗程均为连续治疗12周。采用疼痛视觉模拟(VAS)评分评价治疗前后活动时和静息时疼痛程度;进行治疗前后西安大略和麦克马斯特大学骨关节炎指数可视化量表(WOMAC)评分、膝关节骨性关节炎严重性指数(ISOA),肝肾亏虚证、焦虑自评量表(SAS)和抑郁自评量表(SDS)评分;检测治疗前后血清雌二醇(E
2
),促卵泡生成素(FSH),促黄体生成素(LH),转化生长因子-
β
(TGF-
β
),白细胞介素-1
β
(IL-1
β
),基质金属蛋白酶-3(MMP-3),肿瘤坏死因子-
α
(TNF-
α
)水平。
结果
2
治疗后观察组患者活动时VAS和静息时VAS均低于对照组(
P<
0.01);观察组WOMAC总分及疼痛、僵硬、关节功能3个因子评分均低于对照组(
P<
0.01);观察组患者肝肾亏虚证,SAS和SDS评分均低于对照组(
P<
0.01);观察组ISOA总分和症状体征、最大步行距离、日常生活3个维度评分均低于对照组(
P<
0.01);观察组E
2
水平高于对照组,FSH,LH水平均低于对照组(
P<
0.01);观察组患者TGF-
β
水平高于对照组,TNF-
α
,IL-1
β
和MMP-3水平均低于对照组(
P<
0.01);观察组临床总有效率分别为89.23%(58/65),高于对照组的74.60%(47/63)(
χ
2
=4.793,
P<
0.05)。
结论
2
采用左归丸加减内服从肾论治绝经后KOA肝肾亏虚证患者可明显减轻症状,改善关节功能,调节内分泌激素水平,减轻焦虑、抑郁,并可调节软骨代谢的环境,抑制炎症反应,提高了患者日常生活能力和临床疗效。
Objective
2
To discuss the clinical efficacy of modified Zuoguiwan on postmenopausal osteoarthritis of knee (KOA) with deficiency of liver and kidney based on theory of syndrome differentiation and treatment of kidney
and its effect on endocrine hormone and cartilage metabolism.
Method
2
One hundred and forty patients of KOA were randomly divided into control group (70 cases) and observation group (70 cases) by random number table. Patients in two group got glucosamine hydrochloride capsule for 12 weeks
1 capsule/time
2 times/day
and those with obvious pain was added celecoxib capsules for 4 weeks
0.2 g/time
1 time/day. The control group took Kang Zengsheng pills orally. patients in observation group was also added with modified Zuoguiwan for 12 weeks
1 dose/day. Before and after treatment
pain level during activity and rest by visual simulation of pain (VAS) were scored. And visual scale of osteoarthritis index (WOMAC) of Western Ontario and McMaster University
knee osteoarthritis severity index (ISOA)
deficiency of liver and kidney
self-rating anxiety scale (SAS) and self-rating depression scale (SDS) were scored. And levels of serum estradiol (E
2
)
follicle stimulating hormone (FSH)
luteinizing hormone (LH)
transforming growth factor-
β
(TGF-
β
)
interleukin-1
β
(IL-1
β
)
matrix metalloproteinase-3 (MMP-3) and tumor necrosis factor-
α
(TNF-
α
) were scored.
Result
2
Scores of VAS during activity and rest in observation group were lower than those in control group (
P
<
0.01). The total score of WOMAC
scores of pain
stiffness
joint function
deficiency of liver and kidney
SAS and SDS were all lower than those in control group (
P
<
0.01). Total score of ISOA
symptoms and signs
maximum walking distance
daily life were lower than those in control group (
P
<
0.01). Levels of E
2
FSH
LH
TNF-
α
IL-1
β
and MMP-3 were lower than those in control group (
P
<
0.01). Level of TGF-
β
was higher than that in control group (
P
<
0.01). And total clinical effective rate in observation group was 89.23%(58/65)
which was higher than 74.60%(47/63) in control group (
χ
2
=4.793
P<
0.05).
Conclusion
2
Modified Zuoguiwan can obviously alleviate symptoms
improve joint function
regulate the level of endocrine hormone
relieve anxiety and depression
regulate the environment of cartilage metabolism
inhibit inflammatory reaction
and improve the patients' ability of daily life and clinical efficacy.
中华医学会骨科学分会关节外科学组 . 骨关节炎诊疗指南(2018年版) [J]. 中华骨科杂志 , 2018 , 38 ( 12 ): 705 - 715 .
王欢 , 孙贺 , 张耀南 , 等 . 中国40岁以上人群原发性膝骨关节炎各间室患病状况调查 [J]. 中华骨与关节外科杂志 , 2019 , 12 ( 7 ): 528 - 532 .
卢双晶 , 刘又文 , 王会超 . 雌激素与女性骨关节炎的相关性 [J]. 风湿病与关节炎 , 2014 , 3 ( 4 ): 74 - 76 .
SASAKI E , OTA S , CHIBA D , et al . Early knee osteoarthritis prevalence is highest among middle-aged adult females with obesity based on new set of diagnostic criteria from a large sample cohort study in the Japanese general population [J]. Knee Surg Sports Traumatol Arthrosc , 2020 , 28 ( 3 ): 984 - 999 .
王云秀 , 薛元霞 , 陈月萍 , 等 . 骨代谢指标在老年女性原发性骨关节炎中骨质疏松症的诊断价值 [J]. 热带医学杂志 , 2018 , 18 ( 12 ): 1573 - 1575 .
李平 , 施青 , 李贺 , 等 . 真武汤加味联合整脊手法治疗膝骨关节炎发作期寒湿痹阻证的临床观察 [J]. 中国实验方剂学杂志 , 2019 , 25 ( 23 ): 98 - 103 .
吴柯柯 , 潘建科 , 杨伟毅 , 等 . 曹学伟教授辩证论治围绝经期妇女膝骨关节炎的经验总结 [J]. 按摩与康复医学 , 2018 , 9 ( 5 ): 92 - 94 .
郑子安 , 闻晓婧 , 潘霏 , 等 . 左归丸临床应用及实验研究进展 [J]. 中华中医药学刊 , 2014 , 32 ( 1 ): 58 - 60 .
谭彪 , 孙瑗 , 杨世鹏 . 左归丸加减内服配合玻璃酸钠关节内注射治疗肝肾亏虚型膝骨关节炎近期疗效观察 [J]. 中国社区医师 , 2018 , 34 ( 22 ): 81 - 82 .
中国中医药研究促进会骨科专业委员会 . 膝骨关节炎中医诊疗专家共识(2015年版) [J]. 中医正骨 , 2015 , 27 ( 7 ): 4 - 5 .
张秦 , 陈爱萍 , 邵培培 , 等 . 柴胡加龙骨牡蛎汤加减方治疗绝经女性膝骨关节炎111例疗效观察 [J]. 世界中医药 , 2017 , 12 ( 5 ): 1057 - 1060,1064 .
黄捷 , 薄占东 , 刘刚 , 等 . 早期膝骨关节炎患者血清雌二醇和睾酮水平与病变程度的关系 [J]. 中国组织工程研究 , 2018 , 22 ( 36 ): 5760 - 5765 .
袁祥生 , 李现林 . 李现林教授治疗女性围绝经期骨关节炎经验总结 [J]. 风湿病与关节炎 , 2016 , 5 ( 8 ): 49 - 50 .
李永婷 , 石广霞 , 屠建锋 , 等 . 针灸治疗膝骨关节炎选穴规律分析 [J]. 辽宁中医杂志 , 2017 , 44 ( 10 ): 2179 - 2182 .
赵元 , 郑红霞 , 徐颖 , 等 . 中药植物雌激素的研究进展 [J]. 中国中药杂志 , 2017 , 42 ( 18 ): 3474 - 3487 .
张立智 , 卫禛 , 张世民 . 转化生长因子 β 信号在骨关节炎中的作用 [J]. 中华骨与关节外科杂志 , 2019 , 12 ( 9 ): 727 - 732 .
谌曦 , 刘健 , 黄传兵 , 等 . 健脾补肾通络止痛法联合中药离子导入治疗膝骨关节炎的临床研究 [J]. 中华中医药杂志 , 2015 , 30 ( 3 ): 943 - 946 .
0
浏览量
14
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621